Virtual Medicinal Product (VMP)
-
Tolterodine 4mg modified-release capsules
Name Details
Current Name
Tolterodine 4mg modified-release capsules
|
Start Date
24-10-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release capsule
- Ontology Form/Route
- capsulemodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G04BD07
BNF |
Current BNF
07040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
07040200
|
Start Date
14-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
14608411000001108 |
30-10-2008 |
|
400728002 |
11-08-2005 |
29-10-2008 |
3497711000001102 |
24-10-2002 |
10-08-2005 |
VMP Ingredients
Name
Tolterodine tartrate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
4.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Tolterodine
-
VMP
(Current) Tolterodine 4mg modified-release cap...
Virtual Medicinal Product Pack (VMPP) Information